Capital Building in Washington DC

Advocacy

To improve patient care, ASCO advocates for increased federal funding for research, greater health care access, value in cancer care, and payment reform.

  • New Bipartisan Bill Would Improve Quality of Cancer Research

    The Association for Clinical Oncology (ASCO) released a statement applauding Senators Richard Burr (R-NC) and Ben Cardin (D-MD) for introducing bipartisan legislation to expand access to clinical trials and improve the quality of cancer research in The CLINICAL TREATMENT Act (S. 4742).

    Read More
  • President Signs Continuing Resolution

    President Trump signed into law a Continuing Resolution to fund the federal government through December 11, 2020, but it does not include any emergency or additional funding for the National Institutes of Health to mitigate disruptions to trials/research due to COVID-19.

    Learn More
  • Consider People with Cancer When E-Prescribing Opioids

    The Association for Clinical Oncology (ASCO) responded to a Request for Information on electronic prescribing of controlled substances (EPCS). ASCO supports safe and unburdened access to opioids for people with cancer and asserts that EPCS can improve the quality of cancer care.

    Read Here

Random Quote

"I value the broad exposure ASCO affords my specialty throughout the oncology world. All of us have the opportunity to learn about the latest advances in our field and to broadly share our own research."
Clifford Hudis, MD, FASCO
ASCO CEO